CASTAGNOLI, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 2.225
EU - Europa 1.098
AS - Asia 667
SA - Sud America 20
AF - Africa 10
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 4.032
Nazione #
US - Stati Uniti d'America 2.182
IE - Irlanda 590
CN - Cina 473
SG - Singapore 132
FI - Finlandia 123
DE - Germania 117
IT - Italia 81
SE - Svezia 73
UA - Ucraina 50
CA - Canada 42
IN - India 33
GB - Regno Unito 28
BE - Belgio 14
BR - Brasile 13
GR - Grecia 8
AU - Australia 7
MU - Mauritius 7
NL - Olanda 6
FR - Francia 5
HK - Hong Kong 5
JP - Giappone 5
EU - Europa 4
BD - Bangladesh 3
MY - Malesia 3
CL - Cile 2
IL - Israele 2
IQ - Iraq 2
IR - Iran 2
PE - Perù 2
ZA - Sudafrica 2
AP - ???statistics.table.value.countryCode.AP??? 1
AR - Argentina 1
AT - Austria 1
BO - Bolivia 1
CR - Costa Rica 1
EC - Ecuador 1
ET - Etiopia 1
JO - Giordania 1
KH - Cambogia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
OM - Oman 1
RO - Romania 1
RU - Federazione Russa 1
TH - Thailandia 1
TR - Turchia 1
Totale 4.032
Città #
Dublin 584
Chandler 492
Ashburn 211
Boardman 163
Princeton 124
Lawrence 120
Medford 104
Jacksonville 98
Helsinki 95
Nanjing 85
Singapore 80
Wilmington 75
Beijing 58
Shanghai 58
Ann Arbor 50
Toronto 38
Nanchang 32
Seattle 31
New York 30
Shenyang 27
Changsha 26
Los Angeles 24
Munich 24
Washington 24
Hangzhou 22
Jiaxing 22
Hebei 20
Chicago 19
Fairfield 17
Tianjin 17
Brussels 14
Pavia 12
Pune 12
Woodbridge 12
Norwalk 11
Redwood City 11
Des Moines 10
Milan 9
Dearborn 7
Jinan 6
Falls Church 5
Guangzhou 5
Piacenza 5
Shenzhen 5
Trumbull 5
Wuhan 5
Berlin 4
Dallas 4
Frankfurt am Main 4
Gunzenhausen 4
Hong Kong 4
Kunming 4
Nuremberg 4
San Francisco 4
Zhengzhou 4
Barlassina 3
Charleston 3
Delhi 3
Detroit 3
Dhaka 3
Falkenstein 3
Lancaster 3
Leawood 3
Mainz 3
Melbourne 3
Montichiari 3
Redmond 3
Rome 3
San Mateo 3
Taizhou 3
Tokyo 3
Andover 2
Atlanta 2
Cambridge 2
Canberra 2
Castano Primo 2
Chengdu 2
Cosenza 2
Dalian 2
Dezhou 2
Esslingen am Neckar 2
Gaithersburg 2
Houston 2
Kettering 2
L'hay-les-roses 2
Lima 2
Lodi 2
London 2
Menlo Park 2
Mountain View 2
Mumbai 2
Parma 2
Passirano 2
Ponte Lambro 2
Richmond 2
San Jose 2
Seveso 2
Xi'an 2
Zanjan 2
Addis Ababa 1
Totale 3.045
Nome #
Impact of passive smoke and/or atopy on adenoid immunoglobulin production in children 89
Allergy work-up in a child undergoing general anesthesia, with suspected latex allergy 81
Current recommendations and emerging options for the treatment of allergic rhinitis. 66
Egg allergy: diagnosis and benefit of basophilic activation test 63
Allergic reaction to oral Furosemide 62
A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: A three-center, assessor blinded trial 62
Amiodarone hypersensitivity reaction and basophil activation test 61
Predicting challenge outcomes in children: role of histamine levels 57
From IgE to clinical trials of allergic rhinitis 57
Eosinophilic gastrointestinal disorders in children: An Italian single-center experience 57
Asthma endotyping and biomarkers in childhood asthma 56
ATOPIC DERMATITIS: IS THERE A ROLE FOR PROBIOTICS? 55
Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis 53
The role of upper airway pathology as a co-morbidity in severe asthma 52
Omalizumab in children. 51
Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 48
COVID-19 and autoimmune diseases: is there a connection? 47
Allergen immunotherapy in children and adolescents with respiratory diseases 47
Biomarkers of immunotherapy response in patients with allergic rhinitis 45
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents 45
An update on anti-ige therapy in pediatric respiratory diseases 44
X-Linked Hypohidrotic Ectodermal Dysplasia: New Features and a Novel EDA Gene Mutation 44
Low T-Cell Receptor beta (TRB) Repertoire Diversity Early Post-Transplant for Severe Combined Immunodeficiency (SCID) Predicts Subsequent Failure of Immune Reconstitution 44
Omalizumab for the treatment of chronic idiopathic/spontaneous urticaria in children 43
SARS-CoV-2 infection in pediatric population 43
Clinical and Epidemiological Features of Pediatric Patients with COVID-19 in a Tertiary Pediatric Hospital 42
Omalizumab in children with severe allergic asthma: The Italian real- life experience 42
An update on biological therapies for pediatric allergic diseases 42
Biologic Use in Allergic and Asthmatic Children and Adolescents during the COVID-19 Pandemic 42
Behavioral issues and quality of life in children with eosinophilic esophagitis 41
Timely adaptation of a pediatric unit to COVID-19 emergency in Northern Italy: The experience of Fondazione IRCCS Policlinico San Matteo in Pavia 41
Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares 41
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 41
Food allergies: Current and future treatments 40
Allergen immunotherapy for IgE-mediated food allergy: There is a measure in everything to a proper proportion of therapy 40
Immunomodulation in pediatric asthma 39
Novel biologics for the treatment of pediatric severe asthma 38
Allergy and covid-19 38
Towards precision medicine in pediatric severe asthma: An update on current and emerging biomarkers 37
COVID-19 in the pediatric population admitted to a tertiary referral hospital in Northern Italy: Preliminary clinical data 37
Low T-cell receptor beta (TRB) Repertoire Diversity Early Post-transplant for Severe Combined Immunodeficiency SCID Predicts Subsequent Failure of Immune Reconstitution 37
Association between treatment awareness and uncontrolled asthma in adolescents 36
NGS Reveals Repertoire Restriction of Treg Cells in APDS1 Patients 36
Novel Approaches to the Study of Neonatal Infections 36
Type-2 inflammatory mediators as targets for precision medicine in children 36
An immune-based biomarker signature is associated with mortality in COVID-19 patients. 36
Drug allergy: epidemiology of a cohort of pediatric patient 35
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives 35
An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma 35
Hymenoptera venom allergy among children in Italy: time for pediatricians to take action 35
Updates on new monogenic inborn errors of immunity 35
Eosinophilic esophagitis after congenital diaphragmatic hernia 34
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic 34
An asymptomatic mediastinal cyst in a young child: Case report and summary of the literature 34
Protocols for drug allergy desensitization in children 34
Off-label treatment with Cyclosporine A in a child with severe atopic dermatitis 34
Quantitation of T Cell Repertoire Diversity Following Treatment for SCID 33
Inadequate literacy is associated with uncontrolled asthma in adolescents 33
Emerging drugs for the treatment of perennial allergic rhinitis 32
Personalized therapies for the treatment of allergic rhinitis 32
New approaches for identifying and testing potential new anti-asthma agents 31
Additional Concerns Regarding Children With Coronavirus Disease 2019-Reply 31
The use of basophil activation test to diagnose egg-allergy in children 30
Comprehensive genetic results for primary immunodeficiency disorders in a highly consanguineous population 30
Characterization of Gut Inflammation and Autoimmunity in Mice Carrying Rag1 Hypomorphic Mutations 30
Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C 30
Monoclonal antibodies in pediatric allergy 29
Low T-Cell Receptor β ( ) Repertoire Diversity Early Post-Transplant for Severe Combined Immunodeficiency (SCID) Predicts Subsequent Failure of Immune Reconstitution 29
Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19 29
The discovery and development of omalizumab for the treatment of asthma 28
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review 28
Complete Absence of CD3γ Protein Expression Is Responsible for Combined Immunodeficiency with Autoimmunity Rather than SCID 28
Immunological basis of virus-host interaction in COVID-19 28
Anxiety and depression in adolescents with asthma: a study in clinical practice 28
Urticaria in childhood 27
Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indices 27
Skin tests are important in children with β-lactam hypersensitivity, but may be reduced in number 27
High throughput sequencing reveals repertoire restriction of Treg and CD8(+) T cells in APDS1 patients 27
The Nose and the Lung: United Airway Disease? 26
Rituximab hypersensitivity reaction in a child with nephrotic syndrome: a case report 26
Inborn Errors of Immunity With Immune Dysregulation: From Bench to Bedside 26
Pediatric COVID-19 – a review 25
Tryptase and histamine may support oral food challenge in the diagnosis of allergy 25
Development of a peptide conjugate vaccine for inducing therapeutic anti-IgE antibodies 25
Severe uncontrolled asthma in children: Practical approach on diagnosis and management 25
Identification of gut inflammation and autoimmunity in murine models carrying Rag1 hypomorphic mutations 25
Human inborn errors of immunity caused by defects of receptor and proteins of cellular membrane 25
Pediatric COVID-19 – a review 25
Alpha-Gal Syndrome in Children: Peculiarities of a “Tick-Borne” Allergic Disease 25
Pediatric use of omalizumab for allergic asthma 24
The Measurement of Asthma and Allergic Rhinitis Control in Children and Adolescents 23
Activated phosphoinositide 3-dinase delta syndrome (APDS): An update 23
Measuring inflammation in paediatric severe asthma: Biomarkers in clinical practice 22
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths 21
A compilation answering 50 questions on monkeypox virus and the current monkeypox outbreak 20
Admission rates for respiratory diseases during the covid-19 pandemic: The experience of the pediatric clinic in Pavia 20
Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5–11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP) 19
Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019 19
Eosinophilic Gastrointestinal Diseases in Children: A Practical Review 19
Epidemiology of rare allergic diseases in children 18
Totale 3.688
Categoria #
all - tutte 29.345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.345


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202088 0 0 0 0 0 9 7 10 13 27 21 1
2020/2021315 12 29 7 50 27 52 14 55 8 36 20 5
2021/2022616 13 2 30 3 17 44 4 15 33 96 75 284
2022/20231.529 176 104 32 107 95 152 1 84 696 6 59 17
2023/2024776 76 140 52 45 64 192 48 44 6 51 38 20
2024/2025472 36 185 57 64 49 81 0 0 0 0 0 0
Totale 4.224